Taiwan Hopax Chemicals Manufacturing Co. Ltd. AI Stock Analysis
Taiwan Hopax Chemicals Manufacturing Co. Ltd. (6509) AI Stock Analysis
Taiwan Hopax Chemicals Manufacturing Co. Ltd.
(TPEx:6509)
Taiwan Hopax earns an above-average score driven primarily by sound financials: record profitability, consistently widening margins, a conservative balance sheet with a 0.30 debt-to-equity ratio, and a strong rebound in operating and free cash flow. An undemanding P/E of 12.4 and a 3.0% dividend yield add further support. The main drag is near-term technical weakness — the stock trades below its 20-, 50- and 100-day moving averages with a negative MACD — alongside cyclical revenue that remains below its 2022 peak and a return on equity of roughly 11% that lags prior highs as the capital base grows.
Taiwan Hopax Chemicals Manufacturing Co. Ltd. (6509) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 9.09B
- Dividend Yield
- 3.23%
- Average Volume (3M)
- 887.52K
- Price to Earnings (P/E)
- 13.0
- Beta (1Y)
- 0.73
- Revenue Growth
- 2.00%
- EPS Growth
- 57.23%
- Country
- TW
- Employees
- 891
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Taiwan Hopax Chemicals Manufacturing Co. Ltd. Business Overview & Revenue Model
Company Description
Taiwan Hopax Chemicals Manufacturing Co., Ltd. (Hopax) operates as a global manufacturer and supplier, specializing in a diverse array of chemical solutions. The company's core business encompasses the production and sale of specialty chemicals, fine...
Taiwan Hopax Chemicals Manufacturing Co. Ltd. Financial Statement Overview
Summary
Solid fundamentals across all three statements. The income statement (74) shows record net income of NT$567 million, up 15.8%, with gross margin expanding from 27.7% to 32.3% and net margin nearly doubling since 2020 — though revenue remains cyclical and below the 2022 peak of NT$5.46 billion. The balance sheet (76) is conservatively funded, with equity up to NT$5.25 billion, debt reduced to NT$1.56 billion and a low debt-to-equity ratio of 0.30, offset by an 11% return on equity that trails the 16.8% of 2022. Cash flow (76) rebounded sharply, with operating cash flow more than doubling to NT$1.22 billion and free cash flow of NT$815 million covering net income comfortably, although historical cash generation has been volatile.
Income Statement
74PositiveBalance Sheet
76PositiveCash Flow
76Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.00B | 4.88B | 4.75B | 4.52B | 5.46B | 4.73B |
| Gross Profit | 1.75B | 1.58B | 1.45B | 1.26B | 1.51B | 1.32B |
| EBITDA | 1.32B | 1.11B | 995.96M | 869.08M | 1.08B | 865.80M |
| Net Income | 710.54M | 567.43M | 489.91M | 429.99M | 599.35M | 428.81M |
Balance Sheet | ||||||
| Total Assets | 8.26B | 7.87B | 7.33B | 6.08B | 6.68B | 6.25B |
| Cash, Cash Equivalents and Short-Term Investments | 1.87B | 1.74B | 1.65B | 703.65M | 637.80M | 521.43M |
| Total Debt | 1.27B | 1.56B | 1.40B | 1.45B | 2.07B | 2.04B |
| Total Liabilities | 2.69B | 2.63B | 2.28B | 2.35B | 3.11B | 3.11B |
| Stockholders Equity | 5.57B | 5.25B | 5.04B | 3.73B | 3.56B | 3.14B |
Cash Flow | ||||||
| Free Cash Flow | 559.58M | 814.73M | 266.97M | 881.22M | 342.01M | 105.67M |
| Operating Cash Flow | 960.24M | 1.22B | 546.06M | 1.15B | 679.77M | 355.34M |
| Investing Cash Flow | -371.75M | -484.99M | -284.74M | -254.36M | -299.55M | -331.05M |
| Financing Cash Flow | -476.56M | -730.41M | 657.94M | -783.97M | -232.50M | -115.36M |
Taiwan Hopax Chemicals Manufacturing Co. Ltd. Peers Comparison
Overall Rating
- TW:650969Neutral
TW:370849Neutral
TW:473946Neutral
TW:430644Neutral
TW:498941Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| TW:6509 | 69Neutral | TWD 9.02B | 12.96 | ― | 3.23% | 2.00% | 57.23% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| TW:3708 | 49Neutral | TWD 8.37B | 2.73 | ― | 6.94% | -79.42% | 2756.52% |
| TW:4739 | 46Neutral | TWD 8.41B | 13.42 | ― | 1.41% | 98.05% | 725.72% |
| TW:4306 | 44Neutral | TWD 9.28B | 15.44 | ― | 4.96% | 4.17% | 151.80% |
| TW:4989 | 41Neutral | TWD 10.18B | -37.53 | ― | ― | 63.30% | 87.48% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:6509 | Taiwan Hopax Chemicals Manufacturing Co. Ltd. | 43.20 | 10.94 | 33.93% | |
| TW:3708 | Swancor Holding Co., Ltd. | 93.60 | -27.17 | -22.50% | |
| TW:4306 | Yem Chio Co., Ltd. | 14.10 | 1.26 | 9.80% | |
| TW:4739 | Coremax Corporation | 71.00 | -0.53 | -0.74% | |
| TW:4989 | LCY Technology Corp. | 60.90 | 13.39 | 28.18% | |
| TW:7763 | Johnson Fine Chemical Co Ltd | 141.50 | 66.66 | 89.07% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026